Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated just now
Peer-reviewedCC BY-NC-NDInternal Medicine

Plasma Exchange-Responsive Bulbar Dysfunction in Thymoma-Associated Myasthenia Gravis with Concomitant Lambert-Eaton Myasthenic Syndrome

Abstract

The coexistence of thymoma-associated myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) is rare, and no established therapeutic strategy exists for this condition. We herein report a case of MG-LEMS overlap syndrome (MLOS) in which plasma exchange (PE) effectively treated severe bulbar dysfunction refractory to intravenous immunoglobulin (IVIg). Sequential electrophysiological testing demonstrated an improvement in the low compound muscle action potential amplitudes and post-exercise increments, reflecting LEMS activity. This case highlights that PE may be more efficacious than IVIg for bulbar symptoms in MLOS, particularly with prominent presynaptic involvement, and supports electrophysiological assessment to guide treatment.

Related

  1. When imaging misleads: Severe bulbar myasthenia gravis with a concomitant tectal lesion: A case report.
    Kleber Orlando Mosquera Rodriguez, María de Los Ángeles Álvarez Falcón, Juan Carlos Moreira Holguín +1
    Surgical neurology internationalPeer-reviewedCC BY-NC-SAFull textNeurologyEurope PMCPMC
  2. Clinical correlates of the Haemoglobin to Red Cell Distribution Width ratio in bacterial bloodstream infections and concomitant kidney dysfunction.
    John Nzobokela, David Chisompola, Jay Chibinga +3
    BMC research notesPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
  3. Depressive symptoms and fatigue are independently associated with myasthenia gravis-specific quality of life beyond neurological severity: a cross-sectional study
    Viktorija Ķēniņa, Vladimirs Krutovs, Ieva Glāzere +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textNeurologyCrossref
  4. Case Report: Fulminant sintilimab-associated myocarditis complicated by complete atrioventricular block and suspected myositis-myasthenia gravis overlap syndrome
    Pian Cheng, Xiaolin Zhao, Min Jin +2
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Cardiovascular medicineCrossref
  5. Brolucizumab-Associated Ocular Complications with Concomitant Sub-Tenon Triamcinolone Acetonide: A Multicenter Retrospective Study
    Ryo Ando, Aki Kato, Kenichi Kimoto +8
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{hayashi2026plasma,
  title = {{Plasma Exchange-Responsive Bulbar Dysfunction in Thymoma-Associated Myasthenia Gravis with Concomitant Lambert-Eaton Myasthenic Syndrome}},
  author = {Ryuichiro Hayashi and Takashi Hosaka and Makoto Terada and Shinji Saiki},
  journal = {Internal Medicine},
  year = {2026},
  month = aug,
  doi = {10.2169/internalmedicine.7609-26},
  url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7609-26/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Plasma Exchange-Responsive Bulbar Dysfunction in Thymoma-Associated Myasthenia Gravis with Concomitant Lambert-Eaton Myasthenic Syndrome
AU  - Ryuichiro Hayashi
AU  - Takashi Hosaka
AU  - Makoto Terada
AU  - Shinji Saiki
PY  - 2026
DA  - 2026/08/19
JO  - Internal Medicine
DO  - 10.2169/internalmedicine.7609-26
UR  - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7609-26/_article
AB  - The coexistence of thymoma-associated myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) is rare, and no established therapeutic strategy exists for this condition. We herein report a case of MG-LEMS overlap syndrome (MLOS) in which plasma exchange (PE) effectively treated severe bulbar dysfunction refractory to intravenous immunoglobulin (IVIg). Sequential electrophysiological testing demonstrated an improvement in the low compound muscle action potential amplitudes and post-exercise increments, reflecting LEMS activity. This case highlights that PE may be more efficacious than IVIg for bulbar symptoms in MLOS, particularly with prominent presynaptic involvement, and supports electrophysiological assessment to guide treatment.
SN  - 1349-7235
SN  - 0918-2918
ER  -